Grants and Contributions:
Title:
Tiamat: Unified kinase model for rapid next-generation inhibitor development - PHASE 1a
Agreement Number:
999571
Agreement Value:
$281,243.00
Agreement Date:
Dec 1, 2022 - May 31, 2023
Description:
The project will focus on the extension of the firm's generative AI model to a unified model over a broad set of kinase targets and will include constructing datasets over hundreds of targets, extending the generative model to accommodate many more properties, and improving prediction and optimization capabilities.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5T 1E1
Reference Number:
172-2022-2023-Q3-999571
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
773532932
Recipient Type:
For-profit organization
Recipient's Legal Name:
Variational AI Inc.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410